Skip to main navigation
Skip to search
Skip to main content
Universitas Indonesia Home
Home
Profiles
Research units
Research output
Equipments
Projects
Activities
Press/Media
Search by expertise, name or affiliation
ABVD versus Stanford V Regimen in Unfavorable Classical Hodgkins Lymphoma
Tommy Supit, Zulkifli Amin
Department of Internal Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'ABVD versus Stanford V Regimen in Unfavorable Classical Hodgkins Lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Classical Hodgkin Lymphoma
100%
Hodgkin
100%
Stanford V
100%
Cochrane
50%
Embase
50%
Bleomycin
50%
Doxorubicin
50%
Bahasa
50%
Dari
50%
Stadium
50%
Analisis
50%
Profil
50%
Akan
50%
Dacarbazine
50%
Vinblastine
50%
Medicine and Dentistry
Stanford V
100%
Adriamycin Bleomycin Vinblastine Dacarbazine
100%
Classical Hodgkin Lymphoma
100%
Midazolam
60%
Doxorubicin
20%
Bleomycin
20%
Dacarbazine
20%
Vinblastine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Midazolam
100%
Classical Hodgkin Lymphoma
100%
Doxorubicin
33%
Bleomycin
33%
Vinblastine
33%
Dacarbazine
33%